IVF add-on may be expensive, invasive, and ineffective, study finds

One of the most common add-ons to IVF procedures undertaken in Australia and globally by infertile couples may be a waste of time as well as expensive and invasive, and may even reduce the chances of success, according to a new report in The Lancet.

Oracle reveals new AI-powered EHR, insights from telehealth earnings, and more

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in

October 31, 2024

Pharmalittle: We’re reading about a key Merck drug trial, cheap Wegovy in China, and more

Top of the morning to you, and a fine one it is. Clear blue skies and cool breezes are wafting over the Pharmalot campus, where

November 19, 2024

Kids who survived Super Bowl shooting are scared, suffering panic attacks and sleep problems

Six months after Gabriella Magers-Darger’s legs were burned by sparks from a ricocheted bullet at the Kansas City Chiefs Super Bowl parade in February, the

August 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.